慢性肢体威胁性缺血患者的大隐静脉适用性评估
该研究对223例慢性肢体威胁性缺血(CLTI)患者进行静脉超声测绘评估,发现多数患者大腿段大隐静脉(GSV)直径≥2.5mm或≥3mm,但全腿段适用比例较低。男性与糖尿病与静脉直径>2.5mm独立相关,提示相当比例血运重建候选者可能适合单段GSV旁路术。
要点
- 69.5%的患者同侧大腿GSV≥2.5mm,42.9%全腿GSV≥2.5mm。
- 58.7%的患者同侧大腿GSV≥3mm,23.8%全腿GSV≥3mm。
- 男性(OR 2.32,95%CI 1.28-4.24)和糖尿病(OR 2.17,95%CI 1.15-4.1)与>2.5mm静脉直径相关。
核心结论
- 大多数CLTI患者拥有适用的大腿段GSV,全腿段GSV适用比例也较高。
- 相当数量适合血运重建的患者可能成为单段GSV旁路术的候选者。
研究设计与样本
- 单中心回顾性研究,纳入2016-2025年223例有静脉测绘的CLTI患者,排除既往开放腹股沟下血运重建者,评估GSV直径。
主要发现
- 大腿GSV≥2.5mm:同侧69.5%,任一侧74%;全腿GSV≥2.5mm:同侧42.9%,任一侧46.6%。
- 大腿GSV≥3mm:同侧58.7%,任一侧64.6%;全腿GSV≥3mm:同侧23.8%,任一侧27.4%。
- 102例(45.7%)接受股腘动脉干预,其中腔内46例(20.6%),旁路56例(25.1%)。
- 多因素分析显示男性(OR 2.32,95%CI 1.28-4.24,P=.006)和糖尿病(OR 2.17,95%CI 1.15-4.1,P=.02)与>2.5mm静脉直径相关。
关键数值与推荐
- GSV直径评估标准:大腿段最低2.5mm,全腿段(大腿+小腿)最低3mm。
临床怎么用
- 术前应常规进行静脉测绘以评估GSV适用性,避免因未测绘而错失单段GSV旁路机会。
- 男性及糖尿病患者更可能拥有适用的大腿段GSV,可优先考虑旁路术式。
局限性
- 单中心回顾性设计,结果外推需谨慎。
- 未报告静脉测绘与干预决策的时间关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In patients with chronic limb-threatening ischemia (CLTI), the Best Endovascular vs Best Surgical Therapy in Patients with CLTI (BEST-CLI) trial demonstrated a significant benefit of infrainguinal bypass with single-segment great saphenous vein (GSV). Given the rise of venous ablation and the lack of consistent vein mapping, the prevalence of adequate GSV is poorly defined in current patients with CLTI. Our goal was to assess the availability of adequate GSV in a contemporary CLTI population. METHODS: We conducted a single-center review of unique patients with CLTI (2016-2025) who had vein mapping before an open or endovascular intervention was performed. Patients with a history of prior open infrainguinal revascularizations were excluded. Duplex ultrasound reports were evaluated for GSV diameter. Vein diameter was assessed for a minimum of 2.5 mm throughout the thigh alone and 3 mm throughout the entire leg (thigh and calf). Ipsilateral and contralateral measurements were recorded. Patient and anatomical details were compared and stratified by available GSV. RESULTS: We identified 223 patients. The patients had a mean age of 68.6 years; 64.1% were male, 50.2% were of Black race, and 17.9% were of Hispanic ethnicity. The majority (69.1%) had diabetes mellitus, and 35% were currently smoking. Of these patients, 16.6% had a history of deep vein thrombosis, 18.4% had chronic venous insufficiency, and 0.9% had a prior GSV ablation; 29.1% had a prior ipsilateral infrainguinal endovascular intervention. With respect to duplex-based measurements, thigh GSV ≥2.5 mm alone was seen in 69.5% and 74% of the ipsilateral and either leg, respectively. Entire leg GSV ≥2.5 mm was observed in 42.9% and 46.6% of the ipsilateral and either leg, respectively. Thigh GSV ≥3 mm alone was seen in 58.7% and 64.6% of the ipsilateral and either leg, respectively. Entire leg GSV ≥3 mm was observed in 23.8% and 27.4% of the ipsilateral and either leg, respectively. Overall, 102 patients (45.7%) underwent femoropopliteal intervention, including 46 endovascular (20.6%) and 56 bypass (25.1%) procedures. Among patients undergoing femoropopliteal intervention, 153 (68.6%) had a thigh GSV diameter of ≥2.5 mm and 133 (59.8%) had a diameter of ≥3.0 mm. Male gender (odds ratio, 2.32; 95% confidence interval, 1.28-4.24; P = .006) and diabetes mellitus (odds ratio, 2.17; 95% confidence interval, 1.15-4.1; P = .02) were associated with >2.5 mm vein diameter on multivariable analysis. CONCLUSIONS: The majority of patients with CLTI had adequate thigh GSV, with a high percentage having adequate GSV throughout the entire leg. These findings suggest that a significant number of patients fit for revascularization could be candidates for a single-segment GSV bypass.
引用
- Farber EH, Farber A, King E, et al. Contemporary assessment of great saphenous vein adequacy in patients with chronic limb-threatening limb ischemia. J Vasc Surg. 2026. PMID: 42498185. doi:10.1016/j.jvs.2026.07.072
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。